Artiva Biotherapeutics, Inc. (ARTV)의 가격은 얼마입니까?

Artiva Biotherapeutics, Inc. (ARTV)의 가격은 $11.09입니다.

Artiva Biotherapeutics, Inc. (ARTV)의 시가 총액은 무엇입니까?

Artiva Biotherapeutics, Inc. (ARTV)의 시가 총액은 $542.19M입니다.

Artiva Biotherapeutics, Inc. (ARTV) 가격 이력

Artiva Biotherapeutics, Inc. is a clinical-stage biotechnology firm specializing in the development of natural killer (NK) cell-based treatments for individuals afflicted with autoimmune disorders and various forms of cancer. Its flagship therapeutic candidate, AB-101, is an innovative, ready-to-use (off-the-shelf) NK cell therapy. This treatment is being developed for a broad spectrum of conditions, including autoimmune diseases like lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, systemic lupus erythematosus, and specific anti-neutrophil cytoplasmic antibody-associated vasculitis subtypes such as granulomatosis with polyangiitis/microscopic polyangiitis, in addition to B-cell non-Hodgkin lymphoma. The company's pipeline also includes AB-201, an allogeneic anti-human epidermal growth factor receptor 2 chimeric antigen receptor (CAR)-NK cell candidate, and AB-205, another allogeneic anti-CD5 CAR-NK cell candidate. Established in 2019, Artiva Biotherapeutics is headquartered in San Diego, California.

연도	성과
2026 (TTM)	59.60%
2025	-64.18%
2024	0.00%

연도

성과

2026 (TTM)

59.60%

2025

-64.18%

2024

0.00%

회사	주가	변동률 1년%	국가
Vertex Pharmaceuticals Incorporated VRTX.US	$542.09	38.63%	US
Argenx SE ARGX.US	$1.03K	44.13%	NL
CSL Limited CSL.AX	$121.01	-13.08%	AU
Moderna, Inc. MRNA.US	$138.18	473.58%	US
Lonza Group AG LONN.SW	$752.76	6.28%	CH

회사

주가

변동률 1년%

국가